Meditrina Pharma Raises First Round

Meditrina Pharmaceuticals Inc., an Ann Arbor, Mich.-based drug startup focused on women's health, has raised $4.4 million in first-round funding from the 21st Century Jobs Fund and the Biosciences Research and Commercialization Center at Western Michigan. The company's lead product candidate is an aromatase inhibitor that is being repurposed for the treatment of endometrial thinning prior to endometrial ablations in pre-menopausal women with abnormal uterine bleeding.